Skip to main content

Table 2 Haematological toxicity

From: Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life

 

All grades (%)

Grade 3 (%)

Grade 4 (%)

Leucopenia

19 (16.8)

5 (4.4)

Neutropenia

41 (36.3)

18 (15.9)

4 (3.5)

Febrile neutropenia

1 (0.9)

1 (0.9)

Anaemia

32 (28.3)

3 (2.6)

Thrombocytopenia

8 (7.1)

1 (0.9)

Thrombocytosis

3 (2.6)